(lp0
S'AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results GlobeNewswire  - Mar 20, 2017 AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology.AngioDynamics, Inc.  Receives An Update From Brokers - The De Soto EdgeMean Price Target Of AngioDynamics, Inc.  At $18.25 - Equities Focus'
p1
aS'AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue ... GlobeNewswire  - Mar 14, 2017 AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology.'
p2
aS'AngioDynamics, Inc.  Shares Bought by Thrivent Financial for Lutherans The Cerbat Gem - 14 hours ago AngioDynamics logo Thrivent Financial for Lutherans increased its position in shares of AngioDynamics, Inc.  by 350.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission .'
p3
aS'AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer GlobeNewswire  - Jul 25, 2016 AngioDynamics, Inc. is a leading provider of innovative medical devices used by healthcare professionals for the minimally invasive treatment of cancer and peripheral vascular disease.AngioDynamics names new CFO - Albany Business Review'
p4
aS'AngioDynamics to Participate in Upcoming Investor Conferences GlobeNewswire  - Nov 28, 2016 AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology.'
p5
aS'AngioDynamics Microwave Tissue Ablation System Now CE Marked Zacks.com - Mar 15, 2017 Headquartered in Latham, NY, AngioDynamics Inc.  , a leading provider of minimally invasive medical devices, recently announced the receipt of CE mark for Solero Microwave Tissue Ablation  System.AngioDynamics, Inc.  Receives Consensus Rating of Hold from Brokerages - Chaffey BreezeThe AngioDynamics, Inc.  Rating Lowered to Sell at Zacks Investment Research - Petro Global News 24'
p6
aS'AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders GlobeNewswire  - Nov 15, 2016 ALBANY, N.Y., Nov. 14, 2016  -- AngioDynamics, Inc.  , a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today&nbsp;...'
p7
aS"AngioDynamics Appoints James C. Clemmer as New President and Chief Executive ... GlobeNewswire  - Apr 4, 2016 As part of his employment agreement, AngioDynamics agreed to award Mr. Clemmer 250,000 performance shares, 200,000 options and 50,000 restricted stock units.New CEO named at one of Albany's biggest public companies - Albany Business ReviewAngioDynamics names new CEO - Glens Falls Post-Star"
p8
aS'Stock Returns: Cardiovascular Systems Inc  is Beating ... CML News - Mar 19, 2017 This is a snapshot to compare the stock returns for AngioDynamics Inc  versus Cardiovascular Systems Inc  .'
p9
aS'AngioDynamics Inc.  Moves Higher on Volume Spike for March 08 Equities.com - Mar 8, 2017 AngioDynamics Inc.  traded on unusually high volume on Mar. 08, as the stock gained 1.16% to close at $16.60. On the day, AngioDynamics Inc. saw 342,514 shares trade hands on 1,641 trades. Considering that the stock averages only a daily&nbsp;...ART Advisors LLC Invests $629000 in AngioDynamics, Inc.  - Community Financial News'
p10
a.